Lorne Steinberg Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$579K Sell
629
-100
-14% -$101K 0.14% 57
2025
Q4
$783K Buy
729
+14
+2% +$13.4K 0.18% 55
2025
Q3
$546K Buy
715
+400
+127% +$298K 0.13% 58
2025
Q2
$246K Hold
315
0.06% 66
2025
Q1
$260K Sell
315
-16
-5% -$13.3K 0.08% 64
2024
Q4
$256K Hold
331
0.07% 64
2024
Q3
$293K Hold
331
0.08% 64
2024
Q2
$300K Sell
331
-100
-23% -$80K 0.1% 63
2024
Q1
$335K Buy
431
+16
+4% +$11.4K 0.1% 66
2023
Q4
$242K Sell
415
-187
-31% -$109K 0.08% 67
2023
Q3
$323K Buy
602
+15
+3% +$7.73K 0.12% 62
2023
Q2
$275K Hold
587
0.1% 61
2023
Q1
$202K Hold
587
0.08% 65
2022
Q4
$215K Buy
+587
New +$208K 0.09% 68
2022
Q3
Sell
-1,087
Closed -$352K 66
2022
Q2
$352K Hold
1,087
0.17% 59
2022
Q1
$311K Hold
1,087
0.14% 55
2021
Q4
$300K Hold
1,087
0.13% 57
2021
Q3
$251K Hold
1,087
0.12% 60
2021
Q2
$249K Hold
1,087
0.12% 60
2021
Q1
$203K Buy
+1,087
New +$213K 0.11% 60

Other funds holding LLY

Lorne Steinberg Wealth Management's LLY Position: Q1 2026 in Review

Lorne Steinberg Wealth Management reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $101K and leaving 629 shares worth $579K. The position accounts for 0.14% of the portfolio, ranked #57.

Lorne Steinberg Wealth Management first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. The position peaked at $783K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lorne Steinberg Wealth Management held 629 shares of Eli Lilly worth $579K as of Q1 2026.
  • Lorne Steinberg Wealth Management sold 100 Eli Lilly shares in Q1 2026, an estimated $101K.
  • Eli Lilly made up 0.14% of Lorne Steinberg Wealth Management's portfolio in Q1 2026, its #57 holding.
  • Lorne Steinberg Wealth Management first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
  • Lorne Steinberg Wealth Management's Eli Lilly position peaked at $783K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lorne Steinberg Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.